Concepedia

Author

Boris Labar

University Hospital Centre Zagreb

Also Known As

B Labar, B. (a) Labar, B. Labar, BORIS LABAR, Boris Labar, H. Gerhartz, P. Sonneveld

57

Publications

576

Citations

8

H-Index

7

Concepts

All Affiliations

University Hospital Centre ZagrebRadboud University NijmegenHôtel-Dieu de ParisEuropean Organisation for Research and Treatment of Cancer
BL

About

Boris Labar is an author at University Hospital Centre Zagreb specializing in radiation oncology, protein kinase, and cell signaling.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

12

2

Cell Biology

1

1

12

3

Cell Signaling

1

1

12

4

Cancer Research

1

1

12

5

Oncology

1

1

12

Boris Labar

×

6

Publications

491

Citations

6

H-Index

YearCitations

Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome

Gabriele Ihorst, U. Platzbecker, Ulrich Germing,

Haematologica

2012

208

The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA

S. Keating, Théo de Witte, Stefan Suciu,

British Journal of Haematology

1998

91

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893).

Roel Willemze, Stefan Suciu, E Archimbaud,

PubMed

1997

88

Thalidomide maintenance treatment increases progression-free but not overall survival in elderly patients with myeloma

H. Ludwig, Zdeněk Adam, E Tóthová,

Haematologica

2010

69

Dexamethasone compared to prednisolone for adults with acute lymphoblastic leukemia or lymphoblastic lymphoma: final results of the ALL-4 randomized, phase III trial of the EORTC Leukemia Group

Boris Labar, Stefan Suciu, Roel Willemze,

Haematologica

2010

23

Prognostic significance of constitutive phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase phosphorylation in acute myeloid leukemia

Sanja Prijić, Ivo Ugrina, Boris Labar,

Leukemia & lymphoma/Leukemia and lymphoma

2014

12

Page 1